OR WAIT null SECS
November 19, 2026
Video
James Ip, MD, discusses his new analysis of the RAPID portion of the phase 3 NODE-301 trial, which indicates the efficacy of etripamil in patients who have undergone an incomplete ablation.
November 04, 2026
Tobias Uhe, MD, discusses the results of the Find-AF 2 Watch trial, examining 2 different smart watches as AF monitors in patients with a recent ischemic stroke.
October 23, 2026
Article
The ENRICH-AF trial ultimately did not demonstrate edoxaban’s efficacy, highlighting the need for further stroke prevention strategies for this patient population.
October 01, 2026
Stay up-to-date with the latest FDA approvals, trial readouts, and key clinician insights across cardiovascular care.
September 30, 2026
Jesus Almendral, MD, and Kanika Mody, MD, join the HCPLive team to discuss increases in hypertensive heart disease, heart failure, and other conditions.
September 19, 2026
Selvanayagam shares his thoughts on whether ICDs’ improvements in sudden cardiac death are worth the reduced quality of life.
September 18, 2026
Joseph Selvanayagam, MBBS, discusses the potential of implantable cardioverter-defibrillators to reduce sudden cardiac death among younger patients.
September 17, 2026
Astrid Paul Nordin, MD, PhD, discusses the results of the IDEAL-AF trial, highlighting the efficacy of including LVZ on top of PVI.
September 15, 2026
Jonathan Piccini, MD, discusses his presentation at ESC 2026 discussing the potential benefits of catheter ablation in concomitant HFpEF and AF.
September 09, 2026
Catch up on any stroke-related news you may have missed during 4 action-packed days of presentations and trial readouts at ESC 2026.